메뉴 건너뛰기




Volumn 71, Issue 10, 2005, Pages

Updated U.S. public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis

Author keywords

[No Author keywords available]

Indexed keywords


EID: 29344443486     PISSN: 14882159     EISSN: 14882159     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (63)
  • 1
    • 0030573421 scopus 로고    scopus 로고
    • Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV
    • CDC. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996;45:468-72.
    • (1996) MMWR , vol.45 , pp. 468-472
  • 2
    • 0032523426 scopus 로고    scopus 로고
    • Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis
    • CDC. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR 1998;47(No. RR-7):1-33.
    • (1998) MMWR , vol.47 , Issue.RR-7 , pp. 1-33
  • 3
    • 0035968189 scopus 로고    scopus 로고
    • Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis
    • CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001;50 (No. RR-11):1-52.
    • (2001) MMWR , vol.50 , Issue.RR-11 , pp. 1-52
  • 4
    • 13744249434 scopus 로고    scopus 로고
    • Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services
    • CDC. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR 2005;54(No. RR-2):1-20.
    • (2005) MMWR , vol.54 , Issue.RR-2 , pp. 1-20
  • 6
    • 0037639784 scopus 로고    scopus 로고
    • Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus
    • Havens PL; Committee on Pediatric AIDS. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics 2003;111:1475-89.
    • (2003) Pediatrics , vol.111 , pp. 1475-1489
    • Havens, P.L.1
  • 7
    • 0030831196 scopus 로고    scopus 로고
    • Occupational risk of human immunodeficiency virus infection in health-care workers: An overview
    • Bell DM. Occupational risk of human immunodeficiency virus infection in health-care workers: an overview. Am J Med 1997;102(5B):9-15.
    • (1997) Am J Med , vol.102 , Issue.5 B , pp. 9-15
    • Bell, D.M.1
  • 9
    • 0023667562 scopus 로고
    • Transmission of HIV by human bite
    • Anonymous. Transmission of HIV by human bite. Lancet 1987;ii:522.
    • (1987) Lancet , vol.2 , pp. 522
  • 10
    • 0027536801 scopus 로고
    • The potential for transmission of human immunodeficiency virus through human bites
    • Richman KM, Rickman LS. The potential for transmission of human immunodeficiency virus through human bites. J Acquir Immune Defic Syndr 1993;6:402-6.
    • (1993) J Acquir Immune Defic Syndr , vol.6 , pp. 402-406
    • Richman, K.M.1    Rickman, L.S.2
  • 12
    • 0032855376 scopus 로고    scopus 로고
    • Human bites and the risk of human immunodeficiency virus transmission
    • Pretty IA, Anderson GS, Sweet DJ. Human bites and the risk of human immunodeficiency virus transmission. Am J Forensic Med Pathol 1999;20:232-9.
    • (1999) Am J Forensic Med Pathol , vol.20 , pp. 232-239
    • Pretty, I.A.1    Anderson, G.S.2    Sweet, D.J.3
  • 14
    • 3042726798 scopus 로고    scopus 로고
    • Treatment for adult HIV infection: 2004 Recommendations of the International AIDS Society-USA Panel
    • Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004;292:251-65.
    • (2004) JAMA , vol.292 , pp. 251-265
    • Yeni, P.G.1    Hammer, S.M.2    Hirsch, M.S.3
  • 15
    • 0034545637 scopus 로고    scopus 로고
    • Experience of health-care workers taking postexposure prophylaxis after occupational human immunodeficiency virus exposures: Findings of the HIV Postexposure Prophylaxis Registry
    • Wang SA, Panlilio AL, Doi PA, et al. Experience of health-care workers taking postexposure prophylaxis after occupational human immunodeficiency virus exposures: findings of the HIV Postexposure Prophylaxis Registry. Infect Control Hosp Epidemiol 2000;21:780-5.
    • (2000) Infect Control Hosp Epidemiol , vol.21 , pp. 780-785
    • Wang, S.A.1    Panlilio, A.L.2    Doi, P.A.3
  • 18
    • 0034728916 scopus 로고    scopus 로고
    • Post-exposure prophylaxis for HIV infection
    • Puro V. Post-exposure prophylaxis for HIV infection [Letter]. Lancet 2000;355:1556-7.
    • (2000) Lancet , vol.355 , pp. 1556-1557
    • Puro, V.1
  • 19
    • 0034940153 scopus 로고    scopus 로고
    • Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV
    • Lee LM, Henderson DK. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV. Drug Saf 2001;24:587-97.
    • (2001) Drug Saf , vol.24 , pp. 587-597
    • Lee, L.M.1    Henderson, D.K.2
  • 20
    • 0033731145 scopus 로고    scopus 로고
    • Antiretroviral prophylaxis of health care workers at two urban medical centers
    • Russi M, Buitrago M, Goulet J, et al. Antiretroviral prophylaxis of health care workers at two urban medical centers. J Occup Environ Med 2000;42:1092-100.
    • (2000) J Occup Environ Med , vol.42 , pp. 1092-1100
    • Russi, M.1    Buitrago, M.2    Goulet, J.3
  • 21
    • 0036119587 scopus 로고    scopus 로고
    • One-year study of occupational human immunodeficiency virus postexposure prophylaxis
    • Garb JR. One-year study of occupational human immunodeficiency virus postexposure prophylaxis. J Occup Environ Med 2002;44:265-70.
    • (2002) J Occup Environ Med , vol.44 , pp. 265-270
    • Garb, J.R.1
  • 22
    • 0034946336 scopus 로고    scopus 로고
    • Pan-Thames survey of occupational exposure to HIV and the use of post-exposure prophylaxis in 71 NHS trusts
    • Grime PR, Risi L, Binns C, Carruthers JR, Williams S. Pan-Thames survey of occupational exposure to HIV and the use of post-exposure prophylaxis in 71 NHS trusts. J Infect 2001;42:27-32.
    • (2001) J Infect , vol.42 , pp. 27-32
    • Grime, P.R.1    Risi, L.2    Binns, C.3    Carruthers, J.R.4    Williams, S.5
  • 24
    • 3042784340 scopus 로고    scopus 로고
    • Unexpected drug interactions and adverse events with antiretroviral drugs
    • Moyle G, Boffito M. Unexpected drug interactions and adverse events with antiretroviral drugs. Lancet 2004;364:8-10.
    • (2004) Lancet , vol.364 , pp. 8-10
    • Moyle, G.1    Boffito, M.2
  • 25
    • 0038205534 scopus 로고    scopus 로고
    • Progress in pharmacology and drug interactions from the 10th CROI
    • Andrade A, Flexner C. Progress in pharmacology and drug interactions from the 10th CROI. Hopkins HIV Rep 2003;15:7,11.
    • (2003) Hopkins HIV Rep , vol.15 , pp. 7
    • Andrade, A.1    Flexner, C.2
  • 26
    • 2942724563 scopus 로고    scopus 로고
    • Genes, ethnicity, and efavirenz response: Clinical pharmacology update from the 11th CROI
    • Andrade A, Flexner C. Genes, ethnicity, and efavirenz response: clinical pharmacology update from the 11th CROI. Hopkins HIV Rep 2004;16:1-7.
    • (2004) Hopkins HIV Rep , vol.16 , pp. 1-7
    • Andrade, A.1    Flexner, C.2
  • 27
    • 67649510918 scopus 로고    scopus 로고
    • University of California at San Francisco Center for HIV Information. Database of antiretroviral drug interactions. Available at http://hivinsite. ucsf.edu/InSite?page=ar-00-02.
    • Database of Antiretroviral Drug Interactions
  • 29
    • 0036437783 scopus 로고    scopus 로고
    • Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection
    • Fichtenbaum CJ, Gerber JG. Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection. Clin Pharmacokinet 2002;41:1195-211.
    • (2002) Clin Pharmacokinet , vol.41 , pp. 1195-1211
    • Fichtenbaum, C.J.1    Gerber, J.G.2
  • 30
    • 0036511638 scopus 로고    scopus 로고
    • Understanding drug-drug interactions in the management of HIV disease
    • Edmunds-Obguokiri T. Understanding drug-drug interactions in the management of HIV disease. HIV Clin 2002;14:1-4.
    • (2002) HIV Clin , vol.14 , pp. 1-4
    • Edmunds-Obguokiri, T.1
  • 31
    • 0036148774 scopus 로고    scopus 로고
    • HIV drug interactions: The good, the bad, and the other
    • Rainey PM. HIV drug interactions: the good, the bad, and the other. Ther Drug Monit 2002;24:26-31.
    • (2002) Ther Drug Monit , vol.24 , pp. 26-31
    • Rainey, P.M.1
  • 32
    • 0035188870 scopus 로고    scopus 로고
    • Pharmacokinetic and other drug interactions in patients with AIDS
    • Dasgupta A, Okhuysen PC. Pharmacokinetic and other drug interactions in patients with AIDS. Ther Drug Monit 2001;23:591-605.
    • (2001) Ther Drug Monit , vol.23 , pp. 591-605
    • Dasgupta, A.1    Okhuysen, P.C.2
  • 33
    • 0035967245 scopus 로고    scopus 로고
    • Interactions among drugs for HIV and opportunistic infections
    • Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001;334:984-96.
    • (2001) N Engl J Med , vol.334 , pp. 984-996
    • Piscitelli, S.C.1    Gallicano, K.D.2
  • 34
    • 0037468373 scopus 로고    scopus 로고
    • Occupational exposure to HIV in health care settings
    • Gerberding JL. Occupational exposure to HIV in health care settings. N Engl J Med 2003;348:826-33.
    • (2003) N Engl J Med , vol.348 , pp. 826-833
    • Gerberding, J.L.1
  • 35
    • 3943104125 scopus 로고    scopus 로고
    • Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV
    • Bassett IV, Freedberg KA, Walensky RP. Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis 2004;39:395-401.
    • (2004) Clin Infect Dis , vol.39 , pp. 395-401
    • Bassett, I.V.1    Freedberg, K.A.2    Walensky, R.P.3
  • 36
    • 10744232997 scopus 로고    scopus 로고
    • Antiretroviral drug resistance in human immunodeficiency virus-infected source patients for occupational exposures to healthcare workers
    • Beltrami EM, Cheingsong R, Heneine WM, et al. Antiretroviral drug resistance in human immunodeficiency virus-infected source patients for occupational exposures to healthcare workers. Infect Control Hosp Epidemiol 2003;24:724-30.
    • (2003) Infect Control Hosp Epidemiol , vol.24 , pp. 724-730
    • Beltrami, E.M.1    Cheingsong, R.2    Heneine, W.M.3
  • 37
    • 0038234808 scopus 로고    scopus 로고
    • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 Recommendations of an International AIDS Society-USA Panel
    • Hirsch MS, Brun-Vezinet F, Clotet B, et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003;37:113-28.
    • (2003) Clin Infect Dis , vol.37 , pp. 113-128
    • Hirsch, M.S.1    Brun-Vezinet, F.2    Clotet, B.3
  • 38
    • 0034756776 scopus 로고    scopus 로고
    • Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis
    • Hawkins DA, Asboe D, Barlow K, Evans B. Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis. J Infect 2001;43:12-8.
    • (2001) J Infect , vol.43 , pp. 12-18
    • Hawkins, D.A.1    Asboe, D.2    Barlow, K.3    Evans, B.4
  • 39
    • 0037322805 scopus 로고    scopus 로고
    • Occupationally acquired human immunodeficiency virus (HIV) infection: National case surveillance data during 20 years of the HIV epidemic in the United States
    • Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003;24:86-96.
    • (2003) Infect Control Hosp Epidemiol , vol.24 , pp. 86-96
    • Do, A.N.1    Ciesielski, C.A.2    Metler, R.P.3    Hammett, T.A.4    Li, J.5    Fleming, P.L.6
  • 40
    • 84858525591 scopus 로고    scopus 로고
    • Data to the end of December London, UK: Health Protection Agency Centre for Infections and Collaborators
    • Health Protection Agency Centre for Infections and Collaborators. Occupational transmission of HIV: summary of published reports. March 2005 edition. Data to the end of December 2002. London, UK: Health Protection Agency Centre for Infections and Collaborators. Available at http://www.hpa.org.uk/ infections/topics_az/hiv_and_sti/hiv/occupational.htm.
    • (2002) Occupational Transmission of HIV: Summary of Published Reports. March 2005 Edition
  • 41
    • 1242276103 scopus 로고    scopus 로고
    • Genotypic resistance tests for the management of postexposure prophylaxis
    • Puro V. Genotypic resistance tests for the management of postexposure prophylaxis. Scand J Infect Dis Suppl 2003;(35 Suppl):106:93-8.
    • (2003) Scand J Infect Dis Suppl , vol.106 , Issue.35 SUPPL. , pp. 93-98
    • Puro, V.1
  • 42
    • 0022426871 scopus 로고
    • Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace
    • CDC. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985;34:681-6, 691-5.
    • (1985) MMWR , vol.34 , pp. 681-686
  • 45
    • 0035099551 scopus 로고    scopus 로고
    • A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers
    • King AM, Osterwalder JJ, Vernazza PL. A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers. Swiss Med Wkly 2001;131:10-3.
    • (2001) Swiss Med Wkly , vol.131 , pp. 10-13
    • King, A.M.1    Osterwalder, J.J.2    Vernazza, P.L.3
  • 47
    • 2942527540 scopus 로고    scopus 로고
    • Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of health-care workers
    • Puro V, Francisci D, Sighinolfi L, et al. Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of health-care workers. J Hosp Infect 2004;57:179-82.
    • (2004) J Hosp Infect , vol.57 , pp. 179-182
    • Puro, V.1    Francisci, D.2    Sighinolfi, L.3
  • 48
    • 29344470417 scopus 로고    scopus 로고
    • Post-exposure prophylaxis (PEP) in health care workers (HCWs) after exposure to an HIV-infected source patient (SP) [Poster]. San Francisco, California, February 8-11, Poster no. 887
    • Dong BJ, Harvey A, Aranow RA, et al. Post-exposure prophylaxis (PEP) in health care workers (HCWs) after exposure to an HIV-infected source patient (SP) [Poster]. In: Program and Abstract of the 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, February 8-11, 2004. Poster no. 887.
    • (2004) Program and Abstract of the 11th Conference on Retroviruses and Opportunistic Infections
    • Dong, B.J.1    Harvey, A.2    Aranow, R.A.3
  • 49
    • 0025974954 scopus 로고
    • Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner
    • Shih C-C, Kaneshima H, Rabin L, et al. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis 1991;163:625-7.
    • (1991) J Infect Dis , vol.163 , pp. 625-627
    • Shih, C.-C.1    Kaneshima, H.2    Rabin, L.3
  • 50
    • 0028791836 scopus 로고
    • Prevention of SIV infection in macaques by (R)-9-(2- phosphonylmethoxypropyl) adenine
    • Tsai C-C, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science 1995;270:1197-9.
    • (1995) Science , vol.270 , pp. 1197-1199
    • Tsai, C.-C.1    Follis, K.E.2    Sabo, A.3
  • 51
    • 0031979775 scopus 로고    scopus 로고
    • mne infection depends critically on timing of initiation and duration of treatment
    • mne infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-73.
    • (1998) J Virol , vol.72 , pp. 4265-4273
    • Tsai, C.-C.1    Emau, P.2    Follis, K.E.3
  • 52
    • 0033814480 scopus 로고    scopus 로고
    • Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2)
    • Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000;74:9771-5.
    • (2000) J Virol , vol.74 , pp. 9771-9775
    • Otten, R.A.1    Smith, D.K.2    Adams, D.R.3
  • 53
    • 0032770948 scopus 로고    scopus 로고
    • Severe hepatic failure related to nevirapine treatment
    • Cattelan AM, Erne E, Slatino A, et al. Severe hepatic failure related to nevirapine treatment. Clin Infect Dis 1999;29:455-6.
    • (1999) Clin Infect Dis , vol.29 , pp. 455-456
    • Cattelan, A.M.1    Erne, E.2    Slatino, A.3
  • 54
    • 0034614159 scopus 로고    scopus 로고
    • Adverse effects associated with use of nevirapine in HIV postexposure for 2 health care workers
    • Johnson S, Baraboutis JG, Sha BE, Proia LA, Kessler HA. Adverse effects associated with use of nevirapine in HIV postexposure for 2 health care workers [Letter]. JAMA 2000;284:2722-3.
    • (2000) JAMA , vol.284 , pp. 2722-2723
    • Johnson, S.1    Baraboutis, J.G.2    Sha, B.E.3    Proia, L.A.4    Kessler, H.A.5
  • 55
    • 0000544290 scopus 로고    scopus 로고
    • Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - Worldwide, 1997-2000
    • CDC. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - worldwide, 1997-2000. MMWR 2001;49:1153-6.
    • (2001) MMWR , vol.49 , pp. 1153-1156
  • 56
    • 0030900781 scopus 로고    scopus 로고
    • Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury
    • Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997;336:919-22.
    • (1997) N Engl J Med , vol.336 , pp. 919-922
    • Ridzon, R.1    Gallagher, K.2    Ciesielski, C.3
  • 57
    • 0030744135 scopus 로고    scopus 로고
    • Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus
    • Ciesielski CA, Metler RP. Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus. Am J Med 1997;102(Suppl 5B):115-6.
    • (1997) Am J Med , vol.102 , Issue.SUPPL. 5B , pp. 115-116
    • Ciesielski, C.A.1    Metler, R.P.2
  • 58
    • 0030795491 scopus 로고    scopus 로고
    • Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
    • Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997;102(Suppl 5B):117-24.
    • (1997) Am J Med , vol.102 , Issue.SUPPL. 5B , pp. 117-124
    • Busch, M.P.1    Satten, G.A.2
  • 59
    • 0032915408 scopus 로고    scopus 로고
    • Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: A case series
    • Rich JD, Merriman NA, Mylonakis E, et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999;130:37-9.
    • (1999) Ann Intern Med , vol.130 , pp. 37-39
    • Rich, J.D.1    Merriman, N.A.2    Mylonakis, E.3
  • 60
    • 3242802876 scopus 로고    scopus 로고
    • HIV RNA testing in the context of nonoccupational postexposure prophylaxis
    • Roland ME, Elbeik TA, Kahn JO, et al. HIV RNA testing in the context of nonoccupational postexposure prophylaxis. J Infect Dis 2004;190:598-604.
    • (2004) J Infect Dis , vol.190 , pp. 598-604
    • Roland, M.E.1    Elbeik, T.A.2    Kahn, J.O.3
  • 61
    • 0028824942 scopus 로고
    • Occupational exposure of health carMorbidity and Mortality Weekly Report (MMWR)e workers (HCWs) to human immunodeficiency virus (HIV): Stress reactions and counseling interventions
    • Armstrong K, Gorden R, Santorella G. Occupational exposure of health carMorbidity and Mortality Weekly Report (MMWR)e workers (HCWs) to human immunodeficiency virus (HIV): stress reactions and counseling interventions. Social Work in Health Care 1995;21:61-80.
    • (1995) Social Work in Health Care , vol.21 , pp. 61-80
    • Armstrong, K.1    Gorden, R.2    Santorella, G.3
  • 62
    • 0037098681 scopus 로고    scopus 로고
    • Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids
    • Meienberg F, Bucher HC, Sponagel L, Zinkernagel C, Gyr N, Battegay M. Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids. Swiss Med Wkly 2002;132:321-4.
    • (2002) Swiss Med Wkly , vol.132 , pp. 321-324
    • Meienberg, F.1    Bucher, H.C.2    Sponagel, L.3    Zinkernagel, C.4    Gyr, N.5    Battegay, M.6
  • 63
    • 29344454787 scopus 로고    scopus 로고
    • Postmarketing reporting of adverse drug experiences
    • 21CFR314.80
    • Food and Drug Administration. 21CFR314.80. Postmarketing reporting of adverse drug experiences. Code of Federal Regulations 2005;5:114-7.
    • (2005) Code of Federal Regulations , vol.5 , pp. 114-117


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.